Oncology (Williston Park). 2020 Sep 15;34(9):358-360. doi: 10.46883/ONC.2020.3409.0358.
ONCOLOGY® recently sat down with Tiffany A. Traina, MD, a medical oncologist at Memorial Sloan Kettering (MSK) Cancer Center, to discuss recent developments in breast cancer care, the upcoming clinical trials that may change the standard of care, and her current work in targeting the androgen receptor pathway for patients with triple-negative breast cancer.
ONCOLOGY® 最近采访了纪念斯隆凯特琳癌症中心(MSK)的肿瘤内科医生 Tiffany A. Traina 医学博士,讨论了乳腺癌治疗的最新进展、可能改变护理标准的即将到来的临床试验,以及她目前针对三阴性乳腺癌患者的雄激素受体通路的工作。